Phosphorothioate linkage (PS backbone)
A backbone modification that swaps an oxygen for sulfur, making an oligo far more resistant to enzymes.
A phosphorothioate linkage replaces one of the non bridging oxygen atoms in the phosphate backbone with sulfur. This slows degradation by nucleases and increases binding to plasma proteins, extending how long the oligo stays active in the body.
It is the most common modification in approved single stranded oligonucleotide drugs.
Related terms
Design with these concepts on Syngenis One
Our platform puts the chemistry behind these terms to work, from candidate design to synthesis ready oligo.
One engine, working across the whole business.
Syngenis One (AI Discovery)
Design RNA and DNA candidates from target to synthesis ready oligo in one workflow.
Manufacturing
Australia's only commercial RNA facility. Custom oligonucleotides, ordered through Syngenis One.
Research and Diagnostics
AI led therapeutic programs and an aptamer based diagnostics pipeline.
Clinical
A specialist nucleic acid CRO with in silico trial modelling.
Life Care
Consumer genomics at a mass market price.
Fund
Infrastructure that channels research investment into the pipeline.